These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30273933)

  • 1. The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.
    Burkard T; Trendelenburg M; Daikeler T; Hess C; Bremerich J; Haaf P; Buser P; Zellweger MJ
    PLoS One; 2018; 13(10):e0202105. PubMed ID: 30273933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.
    Mavrogeni S; Smerla R; Grigoriadou G; Servos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Spiliotis G; Kolovou G; Papadopoulos G
    Lupus; 2016 Mar; 25(3):289-95. PubMed ID: 26453663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis.
    Mavrogeni S; Bratis K; Markussis V; Spargias C; Papadopoulou E; Papamentzelopoulos S; Constadoulakis P; Matsoukas E; Kyrou L; Kolovou G
    Lupus; 2013 Jan; 22(1):34-43. PubMed ID: 23035042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging.
    Mavrogeni S; Bratis K; Kolovou G
    Lupus; 2012 Jul; 21(8):821-9. PubMed ID: 22422802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.
    Mavrogeni S; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Bounas A; Tektonidou M; Lliossis SC; Daoussis D; Plastiras S; Karabela G; Stavropoulos E; Katsifis G; Vartela V; Kolovou G
    Lupus; 2018 Apr; 27(4):564-571. PubMed ID: 28927316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features.
    du Toit R; Herbst PG; Ackerman C; Pecoraro AJ; du Toit RH; Hassan K; Joubert LH; Reuter H; Doubell AF
    Lupus; 2020 Oct; 29(11):1461-1468. PubMed ID: 32631204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus.
    Mavrogeni S; Koutsogeorgopoulou L; Dimitroulas T; Markousis-Mavrogenis G; Kolovou G
    Lupus; 2017 Mar; 26(3):227-236. PubMed ID: 27687024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus.
    Ishimori ML; Martin R; Berman DS; Goykhman P; Shaw LJ; Shufelt C; Slomka PJ; Thomson LE; Schapira J; Yang Y; Wallace DJ; Weisman MH; Bairey Merz CN
    JACC Cardiovasc Imaging; 2011 Jan; 4(1):27-33. PubMed ID: 21232700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance.
    Mavrogeni S; Karabela G; Gialafos E; Stavropoulos E; Spiliotis G; Katsifis G; Kolovou G
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):322-7. PubMed ID: 23909889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol.
    Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus.
    Winau L; Hinojar Baydes R; Braner A; Drott U; Burkhardt H; Sangle S; D'Cruz DP; Carr-White G; Marber M; Schnoes K; Arendt C; Klingel K; Vogl TJ; Zeiher AM; Nagel E; Puntmann VO
    Ann Rheum Dis; 2018 Nov; 77(11):1590-1598. PubMed ID: 30077990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus - A prospective cohort study.
    du Toit R; Herbst PG; Ackerman C; Pecoraro AJ; Claassen D; Cyster HP; Reuter H; Doubell AF
    Lupus; 2021 Feb; 30(2):256-268. PubMed ID: 33525979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.
    Abdel-Aty H; Siegle N; Natusch A; Gromnica-Ihle E; Wassmuth R; Dietz R; Schulz-Menger J
    Lupus; 2008 Jun; 17(6):561-7. PubMed ID: 18539710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.
    Zhang Y; Corona-Villalobos CP; Kiani AN; Eng J; Kamel IR; Zimmerman SL; Petri M
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):389-97. PubMed ID: 25352245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children.
    Vijarnsorn C; Noga M; Schantz D; Pepelassis D; Tham EB
    Int J Cardiovasc Imaging; 2017 May; 33(5):699-709. PubMed ID: 28000002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
    Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.
    Mavrogeni S; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Raftakis J; Plastiras S; Noutsias M; Markousis-Mavrogenis G; Kolovou G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):187. PubMed ID: 28716007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.
    Manchuelle A; Pontana F; De Groote P; Lebert P; Fertin M; Baijot M; Hurt C; Lamblin N; Debry N; Schurtz G; Pentiah AD; Sudre A; Remy-Jardin M; Lancellotti P; Van Belle E; Bauters C; Lemesle G; Delhaye C
    Arch Cardiovasc Dis; 2018 Nov; 111(11):686-701. PubMed ID: 29861294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study.
    Seneviratne MG; Grieve SM; Figtree GA; Garsia R; Celermajer DS; Adelstein S; Puranik R
    Lupus; 2016 May; 25(6):573-81. PubMed ID: 26700183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.